Flavor compositions for beverage and personal care applications

By using lecithin and diterpene glycosides or glucosylated diterpene glycosides in flavoring agents, combined with high-speed homogenization and high-pressure homogenization techniques, a stable nano or microemulsion flavor under acidic conditions was prepared by using surfactant systems of lecithin and diterpene glycosides or glucosylated diterpene glycosides in flavoring agents, combined with high-speed homogenization and high-pressure homogenization techniques, a stable nano or microemulsion flavor under acidic conditions was prepared. The agent solves the problems of unstable flavor agents and the use of non-natural active agents in the prior art, and achieves a high flavor oil content and clear and stable composition.

CN115397252BActive Publication Date: 2024-11-22FIRMENICH SA +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202180028280.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-01-27
Filing Date
2021-12-14
Publication Date
2024-11-22
Estimated Expiration
2041-12-14

AI Technical Summary

Technical Problem

The existing flavoring compositions are unstable under acidic conditions and require the use of non-natural surfactants to achieve stable emulsification, making it difficult to meet the market demand for natural alternatives.

Method used

Using a surfactant system containing lecithin and diterpene glycoside or glucosylated diterpene glycoside, combined with the non-polar phase and polar phase of the flavor oil, nano or microemulsions are prepared through high-speed homogenization and high-pressure homogenization technology. , a clear and stable flavoring composition is formed.

Benefits of technology

The flavoring composition is achieved stable under acidic conditions, capable of maintaining a clear appearance and thermodynamic stability under high proportions of flavor oil content, meets the demand for natural surfactants, and is suitable for beverages and personal care products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003888130270000191
    Figure BDA0003888130270000191
  • Figure BDA0003888130270000192
    Figure BDA0003888130270000192
  • Figure BDA0003888130270000201
    Figure BDA0003888130270000201
Patent Text Reader

Abstract

The present invention relates to a composition, which comprises: a surfactant system comprising lecithin and diterpene glycoside and / or glucosylated diterpene glycoside, a non-polar phase comprising flavor oil, and a polar phase. The present invention also relates to a method for preparing the composition of the present invention, and the use of the composition of the present invention in preparing a flavored beverage or a personal care product. In addition, the present invention relates to a beverage or a personal care product comprising the composition of the present invention.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a composition comprising: a surfactant system comprising lecithin and diterpene glycoside and / or glucosylated diterpene glycoside, a non-polar phase comprising flavor oil, and a polar phase. The present invention also relates to a method for preparing the composition of the present invention, and the use of the composition of the present invention in preparing a flavored beverage or a personal care product. In addition, the present invention relates to a beverage or a personal care product comprising the composition of the present invention. Background Art

[0002] For beverage and personal care applications, there is a need for flavor (food flavoring / seasoning) compositions.

[0003] The flavor composition can be in the form of an emulsion comprising a polar phase, an oil phase and a surfactant system. The aqueous phase typically comprises water and / or one or more polar co-solvents and other ingredients. The oil phase is typically dispersed in the aqueous phase to form an oil-in-water emulsion. The dispersed oil phase typically comprises flavor oils and other lipophilic ingredients that can be used optionally.

[0004] The present invention can provide a flavor composition that is clear in appearance upon dilution but is also stable in concentrated and diluted form (in a beverage or personal care product). Stability is ensured over a wide range of temperature and storage conditions.

[0005] In this regard, the flavor composition according to the invention exhibits at least some stability at acidic pH levels. Since the pH of many beverages is usually at an acidic level, a good stability of the flavor emulsion under acidic conditions is advantageous. However, many emulsions according to the prior art are hardly stable under acidic conditions, for example the surfactants used are unstable under acidic conditions.

[0006] Furthermore, the flavor composition of the present invention may also contain sufficiently high amounts of flavor oils without showing any disadvantages with respect to stability or appearance.In order to effectively provide flavor to beverages, foods or consumer products, a certain proportion of flavor oils is required in the flavor composition.

[0007] Since many flavor oils suitable for use in beverages or consumer products have limited solubility in polar solvents such as water, non-naturally occurring surfactants are often used to prepare stable emulsified flavor compositions. However, customers are often skeptical of the presence of non-natural (synthetic) additives in beverages or personal care products. Therefore, there is a high demand for natural (non-synthetic) alternative surfactants that also allow for the preparation of stable emulsified flavor compositions.

[0008] The present invention provides a solution to provide the above advantages and overcome the above disadvantages associated with known flavor compositions. Summary of the invention

[0009] The present invention relates to a composition comprising:

[0010] - a surfactant system comprising

[0011] - lecithin, and

[0012] - diterpene glycosides and / or glucosylated diterpene glycosides,

[0013] - a non-polar phase comprising flavor oils,

[0014] -Polar phase.

[0015] In a specific embodiment, the composition is an emulsion. An emulsion is understood to be a mixture of two lipids that are immiscible due to their different polarities (hydrophobicity and hydrophilicity). In an emulsion, one liquid (dispersed phase or internal phase) is dispersed in another liquid (external phase or continuous phase). Thus, a non-polar phase can be dispersed in a polar phase, or a polar phase can be dispersed in a non-polar phase.

[0016] In one particular embodiment, the non-polar phase is dispersed in the polar phase. In another particular embodiment, the polar phase is dispersed in the non-polar phase. Preferably, the non-polar phase is dispersed in the polar phase.

[0017] In a specific embodiment, the emulsion is a microemulsion. Microemulsions comprising micellar solutions are usually transparent dispersions that spontaneously form without energy input when their compounds are properly mixed with each other. In view of the small size of the dispersed oil droplets, usually within the range of 10 to 300nm, visible light cannot be scattered, so microemulsions show as clear or translucent isotropic solutions. Typical oil-in-water microemulsions are composed of water, cosolvents such as alcohol, oil and one or more surfactants and cosurfactants. A high proportion of oil is feasible for microemulsion systems, which can save transportation and storage costs. Microemulsions are also thermodynamically stable.

[0018] In another specific embodiment, the emulsion is a nanoemulsion. Compared with microemulsions, nanoemulsions are usually prepared by high energy input, such as high pressure homogenization to break large droplets into small droplets. The size of the oil droplets is usually between 5 and 200 nm.

[0019] The composition according to the invention comprises a surfactant system comprising lecithin and a diterpene glycoside and / or a glucosylated diterpene glycoside.

[0020] Surfactant systems are required to obtain thermodynamically stable compositions at least over a certain period of time (e.g., one month). Surfactants (emulsifiers) exhibit amphiphilic properties, which means that they contain both hydrophobic and hydrophilic parts. Based on these structural characteristics, surfactants are surface active, which enables them to reduce the interfacial tension between the polar and nonpolar phases, thereby stabilizing the emulsion.

[0021] In particular, the composition according to the invention comprises lecithin as surface-active compound or surfactant, respectively.

[0022] "Lecithin" can be understood as a mixture of phospholipids. The phospholipids in lecithin include positively charged phospholipids (such as phosphatidylcholine, phosphatidylethanolamine and phosphatidylserine) and negatively charged phospholipids (such as phosphatidic acid, phosphatidylglycerol and phosphatidylinositol). Lecithin is prepared by extracting and purifying phospholipids from naturally occurring products, including but not limited to soybeans, eggs, sunflower or rapeseed (canola / canola) seeds, milk, marine sources and cottonseed. Food grade lecithin can be obtained from commercial sources in liquid, granular and powdered forms. As used herein, the term "lecithin" refers to both a single type of lecithin and a mixture of different types of lecithin.

[0023] In a particular embodiment, the lecithin is obtained from sunflower.Preferably, the lecithin is the lipid lecithin H100.

[0024] In a particular embodiment, lecithin is present in the composition in an amount of 1 to 10 wt%, preferably 2.5 to 7.5 wt%, more preferably 3 to 7 wt%.

[0025] In a particular embodiment, the composition is a nanoemulsion and comprises 3 to 5% by weight of lecithin.

[0026] In a particular embodiment, the composition is a microemulsion and comprises 5 to 7% by weight of lecithin.

[0027] According to the present invention, the surfactant system further comprises a diterpene glycoside and / or a glucosylated diterpene glycoside.

[0028] Diterpene glycosides and glucosylated diterpene glycosides are well known to the skilled person and occur in a variety of plant sources.

[0029] In a specific embodiment, the diterpene glycoside is selected from the group consisting of steviol glycosides, rubusoside, paniculoside IV, suavioside (A1, B1, C1, D1, D2, E, F, G, H, I, J), goshonoside (F1, F2, F3, F4, F5), or any mixture.

[0030] In a particular embodiment, the diterpene glycoside is rubusoside.

[0031] In a specific embodiment, the diterpene glycoside is panicroside IV.

[0032] In a particular embodiment, the diterpene glycoside is rubusa glycoside. Preferably, the rubusa glycoside is selected from the group consisting of rubusa glycoside A, B, C1, D1, D2, E, F, G, H, I, J or any mixture thereof.

[0033] In a particular embodiment, the diterpene glycoside is raspberry glycoside. Preferably, the raspberry glycoside is selected from the group consisting of raspberry glycoside F1, F2, F3, F4, F5 or any mixture thereof.

[0034] In a particular embodiment, the diterpene glycoside is a steviol glycoside.

[0035] "Steviol glycosides" are glycosides of steviol. Specifically, steviol glycosides can be viewed as steviol molecules whose carboxyl hydrogen atoms are replaced by glucose molecules to form esters, while the hydroxyl hydrogens are combined with glucose and rhamnose to form acetals. In addition, steviol glycosides are compounds responsible for the sweet taste of the leaves of the South American plant Stevia rebaudiana Bertoni. The term "steviol glycosides" includes both single steviol glycosides and mixtures of different steviol glycosides.

[0036] In a particular embodiment, the glucosylated diterpene glycoside is a glucosylated steviol glycoside.

[0037] "Glucosylated steviol glycosides" contain 1 to 20 additional glucose units bonded to the parent steviol glycoside. The term "glucosylated steviol glycosides" includes both single glucosylated steviol glycosides and mixtures of different glucosylated steviol glycosides.

[0038] Glucosylated steviol glycosides can be obtained by extracting and purifying steviol glycosides from the dried leaves of Stevia rebaudiana Bertoni, and then reacting these steviol glycosides with glucosyltransferase in the presence of glucose, thereby adding glucose moieties to the parent steviol glycosides. These glucosylated steviol glycosides can be purified by, for example, using adsorption and ion exchange chromatography.

[0039] In the context of the present invention, steviol glycosides and / or glucosylated steviol glycosides serve as further surfactants in addition to lecithin.

[0040] In a particular embodiment, the composition comprises a diterpene glycoside and / or a glucosylated diterpene glycoside in an amount allowing it to act as a surfactant.

[0041] In a particular embodiment, the composition comprises lecithin and diterpene glycoside and / or glucosylated diterpene glycoside in an amount such that the composition is stable, preferably stable at room temperature.

[0042] In a particular embodiment, the composition comprises diterpene glycoside and / or glucosylated diterpene glycoside in an amount of 1 to 40% by weight, preferably 2.5 to 30% by weight.

[0043] In a particular embodiment, the composition comprises diterpene glycosides, preferably in an amount of 1 to 10 wt%, preferably 2.5 to 7.5 wt%, more preferably 3 to 5 wt%. In said particular embodiment, the composition is preferably a nanoemulsion.

[0044] In a particular embodiment, the composition comprises diterpene glycosides in an amount preferably of 15 to 25% by weight, preferably 17 to 22% by weight, more preferably in an amount of 20% by weight. In said particular embodiment, the composition is preferably a microemulsion.

[0045] In a particular embodiment, the composition comprises glucosylated diterpene glycosides in an amount preferably of 15 to 40 wt%, preferably 20 to 30 wt%, more preferably 22 to 28 wt%. In said particular embodiment, the composition is preferably a microemulsion.

[0046] In a specific embodiment, the mass ratio of diterpene glycoside and / or glucosylated diterpene glycoside to lecithin is 20:1 to 1:20, preferably 10:1 to 1:10.

[0047] In a particular embodiment, the mass ratio of flavor oil to diterpene glycoside is greater than 1:1, preferably greater than 2:1, more preferably greater than 4:1.

[0048] In a particular embodiment, the mass ratio of flavor oil to glucosylated diterpene glycoside is greater than 1:10, preferably greater than 1:5, more preferably greater than 1:3.

[0049] In a specific embodiment, the diterpene glycoside is a steviol glycoside selected from the group consisting of stevioside ((4α)-13-[(2-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-ent-kaur-16-ene-18-acid β-D-glucopyranosyl ester), rebaudioside A ((4α)-13-[(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-ent-kaur-6-ene-18-acid β-D-glucopyranosyl ester), -8-acid β-D-pyranosyl glucopyranose), rebaudioside C ((4α)-13-[(O-6-deoxy-α-L-pyranosyl-(1→2)-O-[β-D-pyranosyl-(1→3)]-β-D-pyranosyl)oxy] kaurin-16-ene-18-acid β-D-pyranosyl glucopyranose), dulcoside A ((4α)-13-[[2-O-(6-deoxy-α-L-pyranosyl-β-D-pyranosyl]oxy] β-D-glucopyranosyl]kauri-16-ene-18-oic acid), rebaudioside B ((4α)-13-[(O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranosyl)oxy]kauri-16-ene-18-oic acid), rebaudioside D ((4α)-13-[(O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranosyl)oxy] )oxy]-kauri-16-ene-18-acid 2-O-β-D-glucopyranosyl-β-D-glucopyranosyl ester), rebaudioside E (13-[(O-β-D-glucopyranosyl-(1,2)-O-[β-D-glucopyranosyl)-oxy]-kauri-16-ene-18-acid (4')-O-β-D-glucopyranosyl-deoxy-(1,2)-O-β-D-glucopyranosyl ester), or any other steviol glycoside found in the stevia plant, and mixtures thereof.

[0050] In a specific embodiment, the diterpene glycoside is a steviol glycoside selected from the group consisting of stevioside ((4α)-13-[(2-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]-ent-kaur-16-ene-18-acid β-D-glucopyranosyl ester), rebaudioside A ((4α)-13-[(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]- Kauri-6-ene-8-acid β-D-pyranosyl glucopyranose), rebaudioside C ((4α)-13-[(O-6-deoxy-α-L-pyranosyl-(1→2)-O-[β-D-pyranosyl-(1→3)]-β-D-pyranosyl)oxy] kauri-16-ene-18-acid β-D-pyranosyl glucopyranose), dulcoside A ((4α)-13-[[2-O-(6-deoxy-α-L-pyranosyl-β-D-pyranosyl) [(4α)-13-[(O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranosyl)oxy]kaur-16-ene-18-oic acid), rebaudioside D ((4α)-13-[(O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-glucopyranosyl)oxy]kaur-16-ene-18-oic acid), ]-β-D-pyranoglucopyranosyl)oxy]-kaur-16-ene-18-acid 2-O-β-D-pyranoglucopyranosyl-β-D-pyranoglucopyranosyl ester), rebaudioside E (13-[(O-β-D-pyranoglucopyranosyl-(1,2)-O-[β-D-pyranoglucopyranosyl)-oxy]-kaur-16-ene-18-acid (4')-O-β-D-pyranoglucopyranosyl-deoxy-(1,2)-O-β-D-pyranoglucopyranosyl ester), or any mixture thereof.

[0051] In a specific embodiment, the glucosylated diterpene glycoside is a glucosylated diterpene glycoside selected from the group consisting of glucosylated stevioside, glucosylated rebaudioside A, glucosylated rebaudioside C, glucosylated dulcoside A, glucosylated rebaudioside B, glucosylated rebaudioside D, glucosylated rebaudioside E, or any other glucosylated steviol glycoside, and any mixtures thereof.

[0052] In a specific embodiment, the glucosylated diterpene glycoside is a glucosylated steviol glycoside selected from the group consisting of glucosylated stevioside, glucosylated rebaudioside A, glucosylated rebaudioside C, glucosylated dulcoside A, glucosylated rebaudioside B, glucosylated rebaudioside D, glucosylated rebaudioside E, or any mixture thereof.

[0053] In a specific embodiment, the glucosylated steviol glycoside comprises 1 to 5 additional glucose units bonded to the parent steviol glycoside, preferably 1 to 3 additional glucose units bonded to the parent steviol glycoside.

[0054] The composition according to the invention also comprises a non-polar phase comprising a flavour oil.

[0055] "Non-polar phase" is understood to be the total amount of hydrophobic compounds in the composition according to the invention.

[0056] In a specific embodiment, the non-polar phase may also include one or more other active ingredients selected from the following: oil-soluble pharmaceutical ingredients, oil-soluble nutritional ingredients (e.g., oil-soluble vitamins), oil-soluble colorants, oil-soluble antimicrobial ingredients, oil-soluble defoamers, mouthfeel modifiers, flavor modifiers, and any combination thereof. Useful flavor modifiers include acid masking agents, polyglycerol (polyaldo) bases, hops, cooling agents, spicy substances, sweet enhancers, salt enhancers, saliva secretion inducing substances, substances that cause warmth or tingling, and any combination thereof. Exemplary mouthfeel modifiers are coconut oil, sugared or sugar-free coconut milk, vanillin, medium chain triglycerides, and combinations thereof. At least one cooling compound is selected from the group consisting of: 2-(4-ethylphenoxy)-N-(1H-pyrazol-5-yl)-N-(2-thienylmethyl)acetamide, WS-23 (2-isopropyl-N,2,3-trimethylbutanamide), FEMA 3804; WS-3 (N-ethyl-p-menthane-3-carboxamide), FEMA 3455; WS-5 [3-(p-menthane-3-carboxamido)ethyl acetate], FEMA 4309; WS-12 (1R,2S,5R)-N-(4-methoxyphenyl)-p-menthanecarboxamide, FEMA 4681; WS-27 (N-ethyl-2,2-diisopropylbutanamide), FEMA 4557; N-cyclopropyl-5-methyl-2-isopropylcyclohexanecarboxamide, FEMA 4693, WS-116 (N-(1,1-dimethyl-2-hydroxyethyl)-2,2-diethylbutanamide), N-(1,1-dimethyl-2-hydroxyethyl)-2,2-diethylbutanamide, FEMA 4603, menthyl alcohol, FEMA 4154, N-(4-cyanomethylphenyl)-p-menthanecarboxamide, FEMA 4496; N-(2-(pyridin-2-yl)ethyl)-3-p-menthanecarboxamide, FEMA 4549; N-(2-hydroxyethyl)-2-isopropyl-2,3-dimethylbutanamide, FEMA 4602 and (also N-(4-(carbamoylmethyl)phenyl)-menthanecarboxamide, FEMA 4684; (1R,2S,5R)-N-(4-methoxyphenyl)-p-menthanecarboxamide (WS-12), FEMA 4681; (2S,5R)-N-[4-(2-amino-2-oxoethyl)phenyl]-p-menthanecarboxamide, FEMA 4684; and N-cyclopropyl-5-methyl-2-isopropylcyclohexanecarboxamide, FEMA 4693; 2-[(2-p-menthoxy)ethoxy]ethanol, FEMA 4718; (2,6-diethyl-5-isopropyl-2-methyltetrahydropyran, FEMA 4680); trans-4-tert-butylcyclohexanol, FEMA 4724;2-(p-Tolyloxy)-N-(1H-pyrazol-5-yl)-N-((thiophen-2-yl)methyl)acetamide, FEMA 4809; Menthone glycerol ketal, FEMA 3807; Menthone glycerol ketal, FEMA 3748; (-)-menthoxypropane-1,2-diol; 3-(1-menthoxy)-2-methylpropane-1,2-diol, FEMA 3849; isopulegol; (+)-cis and (-)-trans-p-menthane-3,8-diol, ratio ~62:38, FEMA 4053; 2,3-dihydroxy-p-menthane; 3,3,5-trimethylcyclohexanone glycerol ketal; menthyl pyrrolidone formate; (1R,3R,4S)-3-menthyl-3,6-dioxaheptanoate; (1R,2S,5R)-3-menthyl methoxyacetate; (1R,2S,5R)-3-menthyl 3,6,9-trioxadecanoate; (1R,2S,5R)-3-menthyl 3,6,9-trioxadecanoate; (1R,2S,5R)-3-menthyl (2-hydroxyethoxy)acetate; (1R,2S,5R)-menthyl 11-hydroxy-3,6,9-trioxaundecanoate; cubebol, FEMA 4497; N-(4-cyanomethylphenyl)-p-menthane carboxamide, FEMA 4496; 2-isopropyl-5-methylcyclohexyl-4-(dimethylamino)-4-oxobutanoate, FEMA 4230; N-(4-cyanomethylphenyl)-p-menthanecarboxamide, FEMA 4496; N-(2-pyridin-2-ylethyl)-p-menthanecarboxamide, FEMA 4549; Menthyl lactate, FEMA 3748; 6-isopropyl-3,9-dimethyl-1,4-dioxaspiro[4.5]decan-2-one, FEMA 4285; N-benzo[l,3]dioxol-5-yl-3-p-menthanecarboxamide; N-(1-isopropyl-1,2-dimethylpropyl)-1,3-benzodioxol-5-carboxamide; N-(R)-2-oxotetrahydrofuran-3-yl-(1R,2S,5R)-p-menthane-3-carboxamide; a mixture of 2,2,5,6,6-pentamethyl-2,3,6,6a-tetrahydropentalen-3a(lH)-ol and 5-(2-hydroxy-2-methylpropyl)-3,4,4-trimethylcyclopent-2-en-1-one; (1R,2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl)cyclohexanecarboxamide, FEMA 4549; (2S,5R)-2-isopropyl-5-methyl-N-(2-(pyridin-4-yl)ethyl)cyclohexanecarboxamide; N-(4-cyanomethylphenyl)-p-menthanecarboxamide, FEMA 4496; (1S,2S,5R)-N-(4-(cyanomethyl)phenyl)-2-isopropyl-5-methylcyclohexanecarboxamide;1 / 7-isopropyl-4 / 5-methyl-bicyclo[2.2.2]oct-5-ene derivatives; 4-methoxy-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benzamide; 4-methoxy-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benzenesulfonamide; 4-chloro-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benzenesulfonamide; 4-cyano-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benzenesulfonamide; 4-((benzhydrylamino)methyl)-2-methoxyphenol; 4-((bis(4-methyl) 4-((Benzhydryloxy)methyl)-2-methoxyphenol, 4-((9H-fluoren-9-ylamino)methyl)-2-methoxyphenol; 4-((Benzhydryloxy)methyl)-2-methoxyphenol; 4-((Benzhydryloxy)methyl)-2-ethoxyphenol; 1-(4-methoxyphenyl)-2-(1-methyl-1H-benzo[d]imidazol-2-yl)vinyl 4-methoxybenzoate; 2-(1-isopropyl-6-(4-methoxybenzoate)-4-((Benzhydryloxy)methyl)-2-methoxyphenol, 4-((9H-fluoren-9-ylamino)methyl)-2-methoxyphenol; 4-((Benzhydrylamino)methyl)-2-ethoxyphenol; 1-(4-methoxyphenyl)-2-(1-methyl-1H-benzo[d]imidazol-2-yl)vinyl 4-methoxybenzoate; 2-(1-isopropyl-6-(4-methoxybenzoate)-4-((Benzhydryloxy)methyl)-2-methoxyphenol, 4-((9H-fluoren-9-ylamino)methyl)-2-methoxyphenol methyl-1H-benzo[d]imidazol-2-yl)-1-(4-methoxyphenyl)vinyl ester; (Z)-2-(1-isopropyl-5-methyl-1H-benzo[d]imidazol-2-yl)-1-(4-methoxy-phenyl)vinyl-4-methoxybenzoate; 3-alkyl-p-menthen-3-ol derivatives; derivatives of fenchyl, D-bornyl, L-bornyl, exo-norbornyl, 2-methylisobornyl, 2-ethylfenchyl, 2-methylbornyl, cis-pin-2-yl, verbanyl and isobornyl; menthyl oxalate derivatives; 3-oxoformyl menthyl ;N-α-(menthanecarbonyl)amino acid amides;p-menthanecarboxamide and WS-23 analogs;(-)-(1R,2R,4S)-dihydroumbellulol;p-menthanealkoxyamides;cyclohexane derivatives;butone derivatives;mixtures of 3-menthanyloxy-1-propanol and 1-menthanyloxy-2-propanol;1-[2-hydroxyphenyl]-4-[2-nitrophenyl-]-1,2,3,6-tetrahydropyrimidin-2-one;4-methyl-3-(1-pyrrolidinyl)-2[5H]-furanone;and combinations thereof. ;

[0057] In a particular embodiment, the non-polar phase is present in the composition in an amount of 1 to 50 wt %, preferably 5 to 40 wt %, based on the total amount of the composition.

[0058] In a particular embodiment, the non-polar phase consists of flavor oils.

[0059] In a particular embodiment, the composition comprises flavor oil in an amount of 1 to 50% by weight, preferably 5 to 40% by weight.

[0060] In another particular embodiment, the composition comprises flavor oil in an amount of 1 to 20 wt%, preferably 2 to 15 wt%, more preferably 5 to 8 wt%. In said embodiment, the composition is preferably a nanoemulsion.

[0061] In another particular embodiment, the composition comprises flavor oil in an amount of 20 to 40 wt%, preferably 25 to 39 wt%. In said embodiment, the composition is preferably a microemulsion.

[0062] By "flavor oil" (or "seasoning oil"), it is meant here a flavoring ingredient, or a mixture of flavoring ingredients, solvents or adjuvants currently used to prepare flavoring formulations, i.e. a specific mixture of ingredients intended to be added to a composition to impart, improve or modify its organoleptic properties, in particular its flavor and / or taste. Taste modifiers are also included in the definition. Flavoring ingredients are well known to those skilled in the art, and their properties do not warrant a detailed description here, in any case they are not exhaustive, and a skilled flavorist can select them according to his general knowledge and according to the intended use or application and the organoleptic effect he wishes to achieve. Many of these flavoring ingredients are listed in the references, for example S. Arctander's book Perfume and Flavor Chemicals, 1969, Montclair, NJ, USA or its latest version, or other works of similar nature, such as Fenaroli's Handbook of Flavor Ingredients, 1975, CRC Press or MB Jacobs' Synthetic Food Adjuncts, 1947, van Nostrand Co., Inc. Solvents and adjuvants currently used in preparing flavoring formulations are also well known in the art.

[0063] In a particular embodiment, the flavor oil comprises limonene. Preferably, the flavor oil consists of limonene.

[0064] In a particular embodiment, the flavor oil comprises grapefruit oil. Preferably, the flavor oil consists of grapefruit oil.

[0065] The composition according to the invention also comprises a polar phase.

[0066] "Polar phase" is understood to be the total amount of hydrophilic compounds in the composition according to the invention.

[0067] In a particular embodiment, the polar phase is present in the composition in an amount of 20 to 90 weight percent, based on the total weight of the composition.

[0068] In another specific embodiment, the polar phase is present in the composition in an amount of 70 to 90 wt%, preferably 78 to 85 wt%, based on the total weight of the composition. In said embodiment, the composition is preferably a nanoemulsion.

[0069] In another specific embodiment, the polar phase is present in the composition in an amount of 20 to 60 wt%, preferably 30 to 55 wt%, based on the total weight of the composition. In said embodiment, the composition is preferably a microemulsion.

[0070] In a particular embodiment, the polar phase comprises water. Preferably, the amount of water in the polar phase is from 60 to 100 wt.-%, based on the total weight of the polar phase.

[0071] In another particular embodiment, the amount of water in the polar phase is preferably higher than 80 wt%, more preferably 100 wt%, based on the total weight of the polar phase. In said embodiment, the composition is preferably a nanoemulsion.

[0072] In another particular embodiment, the polar phase consists of water. In said embodiment, the composition is preferably a nanoemulsion.

[0073] In another particular embodiment, the amount of water in the polar phase is preferably 20 to 60 wt%, more preferably 30 to 55 wt%, based on the total weight of the polar phase. In said embodiment, the composition is preferably a microemulsion.

[0074] In a particular embodiment, the amount of water in the composition is 10 to 90 wt%, more preferably 20 to 85 wt%, based on the total weight of the composition.

[0075] In another specific embodiment, the amount of water in the composition is preferably 70 to 90 wt %, more preferably 78 to 85 wt %, based on the total weight of the composition. In the embodiment, the composition is preferably a nanoemulsion,

[0076] In another specific embodiment, the amount of water in the composition is preferably 15 to 35 wt%, more preferably 20 to 30 wt%, based on the total weight of the composition. In said embodiment, the composition is preferably a microemulsion.

[0077] In a particular embodiment, the polar phase comprises a polar non-aqueous solvent.

[0078] "Polar non-aqueous solvent" is understood to be a polar (hydrophilic) solvent that is not water.

[0079] In a particular embodiment, the non-aqueous solvent is a food grade solvent, particularly a non-aqueous solvent for use in food compositions, particularly in combination with flavor ingredients.

[0080] In a specific embodiment, the polar phase comprises a non-aqueous solvent selected from the group consisting of glycerol, 1,2-propylene glycol, benzyl alcohol, ethanol, propanol, isopropanol, 1,3-propylene glycol, butanol, butanediol, hexylene glycol, dipropylene glycol, ethoxydiglycol, triacetin, or any mixture thereof. Preferably, the polar non-aqueous solvent is glycerol or 1,2-propylene glycol, more preferably, the polar non-aqueous solvent is 1,2-propylene glycol.

[0081] In a specific embodiment, the polar phase is composed of a non-aqueous solvent selected from the group consisting of glycerol, 1,2-propylene glycol, benzyl alcohol, ethanol, propanol, isopropanol, 1,3-propylene glycol, butanol, butanediol, hexylene glycol, dipropylene glycol, ethoxydiglycol, triacetin, or any mixture thereof. Preferably, the polar non-aqueous solvent is glycerol or 1,2-propylene glycol, more preferably, the polar non-aqueous solvent is 1,2-propylene glycol.

[0082] In a particular embodiment, the polar phase consists of water and a non-aqueous solvent selected from the group consisting of glycerol, 1,2-propylene glycol, benzyl alcohol, ethanol, propanol, isopropanol, 1,3-propylene glycol, butanol, butanediol, hexylene glycol, dipropylene glycol, ethoxydiglycol, triacetin, or any mixture thereof. Preferably, the polar phase consists of water and 1,2-propylene glycol.

[0083] In a particular embodiment, the polar non-aqueous solvent is present in the polar phase in an amount of 20 to 60 wt%, preferably 25 to 56 wt%, based on the total amount of the polar phase. In said embodiment, the composition is preferably a microemulsion.

[0084] In a particular embodiment, the polar non-aqueous solvent is present in the composition in an amount of 5 to 40 wt%, preferably 10 to 25 wt%, based on the total weight of the composition. In such an embodiment, the composition is preferably a microemulsion.

[0085] In a particular embodiment, the composition comprises a stabilizer. Preferably, the stabilizer is ester gum (trirosin acid glyceryl). Preferably, the stabilizer is present in the composition in an amount of 2 to 10 wt %, more preferably 2 to 4 wt %, based on the total weight of the composition.

[0086] In a specific embodiment, the composition according to the present invention also comprises one or more antioxidants. Generally, antioxidants are compounds that inhibit oxidation. Antioxidants can be divided into two categories, depending on whether they are dissolved in polar solvents (hydrophilic antioxidants) or dissolved in non-polar solvents (lipophilic antioxidants). The example of hydrophilic antioxidants is ascorbic acid (vitamin C), green tea extract, water-soluble rosemary extract, glutathione, lipoic acid and uric acid. The example of hydrophobic antioxidants is carotene, tocopherol (vitamin E), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), oil-soluble rosemary extract and panthenol (coenzyme Q). In the case where the composition is an emulsion, the antioxidant will be present in the polar phase or the non-polar phase according to its hydrophilic / lipophilic properties.

[0087] In a specific embodiment, the composition also includes one or more vitamins. Vitamin is an organic molecule (or a group of related molecules), which is an essential micronutrient that an organism needs in small amounts to maintain its normal metabolic function. Similar to the above antioxidant, vitamins can be divided into two categories, depending on whether they are soluble in polar solvents (hydrophilic vitamins) or in non-polar solvents (lipophilic vitamins). Examples of hydrophilic vitamins are vitamin C (ascorbic acid) and B vitamins (e.g., B1, B2, B3, B5, B6, B7, and B12). Examples of hydrophobic vitamins are vitamin A, vitamin D, vitamin E, and vitamin K. If the composition is an emulsion, the vitamin will be present in the polar or non-polar phase according to its hydrophilic / lipophilic properties. In some cases, the compound is both an antioxidant and a vitamin, such as vitamin C (ascorbic acid), vitamin E (tocopherol). Preferably, the composition includes vitamin E and / or vitamin C as an antioxidant.

[0088] In a specific embodiment, the composition also includes one or more sugars. Sugar is a general term for sweet carbohydrates that are soluble in polar solvents (such as water). In particular, the term "sugar" refers to monosaccharides, such as glucose, fructose and galactose, and disaccharides, such as sucrose, lactose and maltose. Longer chain sugar molecules are not considered sugars, but are called oligosaccharides or polysaccharides. In the case of emulsions, sugar compounds are present in the polar phase due to their hydrophilic properties.

[0089] In a specific embodiment of the present invention, the composition further comprises one or more defoamers. Defoamers or antifoaming agents are chemical additives that reduce and hinder foam formation, particularly in liquids used in industrial processes. Defoamers can be water-dispersible defoamers or oil-soluble defoamers. Examples include silicone emulsion antifoamers, polydimethylsiloxane antifoamers, 2-octanol, vaseline, hop lipids, alginates, mineral oils, sorbitan monostearate, and combinations thereof.

[0090] In a particular embodiment, the composition is clear in appearance, ie, a clear composition. Compositions having an NTU value of less than 10 are considered to have a clear appearance.

[0091] The present invention also relates to a method for preparing the composition as described above, comprising the following steps:

[0092] - A non-polar phase comprising flavour oils is mixed with a polar phase in the presence of a surfactant system comprising lecithin and diterpene glycosides and / or glucosylated diterpene glycosides.

[0093] In a particular embodiment, the diterpene glycoside and / or the glucosylated diterpene glycoside are present in the polar phase before the mixing of the non-polar phase with the non-polar phase. Preferably, the polar phase comprises water and / or a non-aqueous solvent as described above. Preferably, the polar phase is mixed with the diterpene glycoside and / or the glucosylated diterpene glycoside at a temperature of 20 to 25° C. (room temperature) before mixing with the non-polar phase.

[0094] In a particular embodiment, lecithin is present in the non-polar phase prior to mixing the non-polar phase with the non-polar phase. Preferably, the non-polar phase consists of flavor oils. Preferably, the non-polar phase is mixed with lecithin at a temperature of 20 to 25° C. (room temperature) prior to mixing with the polar phase.

[0095] In a specific embodiment, the mixing of the non-polar phase and the polar phase is carried out by using a high-speed homogenizer at 5000 to 15000 rpm, preferably 8000 to 12000 rpm, more preferably 10000 rpm. Preferably, high-speed homogenization is carried out for 1 to 10 minutes (min), preferably 5 minutes (min). Preferably, German IKA, T25 Digital Ultra Used as a high-speed homogenizer.

[0096] In a specific embodiment, the high-speed homogenization as described above is followed by a high-pressure homogenization step. Preferably, high-pressure homogenization is performed at 50 / 450 bar using a 2-stage high-pressure homogenizer. Preferably, high-pressure homogenization is performed 3 times in a row. Preferably, the high-pressure homogenizer used is an American SPXFLOW, APV-1000 laboratory homogenizer. Preferably, a nanoemulsion is obtained after high-pressure homogenization.

[0097] In a particular embodiment, the mixing of the non-polar phase with the polar phase is performed on a stirring plate at a temperature of 20 to 25° C. (room temperature).

[0098] The present invention also relates to a method for preparing a flavored beverage or a personal care product, comprising the following steps:

[0099] - Adding the composition according to the invention to a beverage or a personal care product.

[0100] The invention also relates to the use of the composition according to the invention for preparing a flavoured beverage or a personal care product.

[0101] The composition according to the invention can be used for preparing flavored beverages.

[0102] The term "flavored beverages" includes flavored and cream sodas, powdered soft drinks, and liquid concentrates such as fountain syrups and cordials; coffee and coffee-based beverages, coffee substitutes and cereal beverages; tea, including dry mix products and ready-to-drink teas (herbal and tea-based); fruit and vegetable juices and juice-flavored beverages as well as juice drinks, nectars, concentrates, punches and various fruit drinks ("ades"); carbonated and still sweetened and flavored waters; sports / energy / health drinks; alcoholic beverages plus non-alcoholic and other low-alcohol products, including beer and malt beverages, cider and wine (still, sparkling, fortified wine and wine coolers); other beverages that are thermally processed (infused, pasteurized, ultra-high temperature, electrically heated or commercially aseptically sterilized) and packaged in hot-fill packaging; and cold-fill products made by filtration or other preservation technologies.

[0103] In the case where the composition is used to prepare a flavored beverage, the compounds contained in the composition must be selected to make it suitable for human consumption. For example, the above-mentioned polar non-aqueous solvents must be selected to make them suitable for human consumption. Therefore, butanediol and hexylene glycol should not be present in the composition for preparing a flavored beverage according to the present invention.

[0104] The compositions according to the invention can also be used for the preparation of personal care products.

[0105] Personal care products are typically applied to the human body to cleanse, beautify, enhance attractiveness or change its appearance. A personal care product is, for example, a toothpaste or a mouthwash.

[0106] In a particular embodiment, the composition of the present invention is used to prepare an oral care product, preferably a mouthwash. Mouthwashes or mouthwashes are liquid oral care formulations that clean and freshen the oral cavity or oral surfaces by inhibiting or killing microorganisms that cause bad odor, caries, tooth decay, gum disease, gingivitis and periodontal disease.

[0107] The invention also relates to a beverage or a personal care product comprising the composition according to the invention.

[0108] In a particular embodiment, the beverage or personal care product comprises a composition according to the present invention in an amount of 0.001 to 5% by weight, preferably 0.01 to 0.1% by weight, based on the total weight of the beverage or personal care product.

[0109] In a particular embodiment, the beverage is an alcoholic or non-alcoholic beverage, preferably, the beverage is a non-alcoholic beverage.

[0110] In a particular embodiment, the personal care product is an oral care product, preferably a mouthwash. The mouthwash may be an alcoholic or non-alcoholic mouthwash.

[0111] In a particular embodiment, the beverage or personal care product exhibits a turbidity (NTU) of less than 10. Preferably, the turbidity (NTU) is from 4 to 9.9. When the composition according to the invention is a microemulsion, the turbidity (NTU) is preferably from 4.5 to 6.

[0112] NTU value refers to "nephelometric turbidity unit" representing the turbidity of the composition and is measured by a turbidimeter specified by the U.S. Environmental Protection Agency. Preferably, turbidity is measured by a portable turbidity meter (Hanna Instruments, Woonsocket, RI, HI93703). Typically, beverages or personal care products with NTU values ​​higher than 15 can be considered to be turbid and unclear. In contrast, beverages and personal care products with NTU values ​​less than 10 can be considered to have a clear appearance.

[0113] In a particular embodiment, the beverage or personal care product exhibits a droplet size of the dispersed phase of 30 to 150 nm, preferably 45 to 130 nm. The droplet size is preferably measured by Zetasizer nano ZS (Malvern Panalytical Limited, Worcs, UK). When the composition according to the invention is a microemulsion, the droplet size of the dispersed phase is preferably 95 to 125 nm. When the composition according to the invention is a nanoemulsion, the droplet size of the dispersed phase is preferably 48 to 96 nm.

[0114] In a particular embodiment, the beverage exhibits a pH value of 2.5 to 7, preferably 2.5 to 4.0.

[0115] Since the composition of the present invention exhibits sufficient stability under acidic conditions, it may also be present in beverages exhibiting an acidic pH value.

[0116] In a particular embodiment, the flavor oil is present in the beverage in an amount of 1 to 1000 ppm (parts per million), preferably 10 to 500 ppm, more preferably 20 to 100 ppm, based on the total weight of the beverage or personal care product.

[0117] In a particular embodiment, the flavor oil is present in the personal care product in an amount of 0.001 to 0.5 wt %, preferably 0.01 to 0.25 wt %, based on the total weight of the personal care product.

[0118] In a particular embodiment, the diterpene glycoside is present in the beverage or personal care product in an amount of 10 to 100 ppm (parts per million) based on the total weight of the beverage or personal care product.

[0119] In a particular embodiment, the steviol glycosides are present in the beverage or personal care product in an amount of 10 to 100 ppm (parts per million) based on the total weight of the beverage or personal care product.

[0120] In a particular embodiment, the glucosylated diterpene glycoside is present in the beverage or personal care product in an amount of 10 to 150 ppm (parts per million), preferably 20 to 125 ppm, based on the total weight of the beverage or personal care product.

[0121] In a particular embodiment, the glucosylated steviol glycoside is present in the beverage or personal care product in an amount of 10 to 150 ppm (parts per million), preferably 20 to 125 ppm, based on the total weight of the beverage or personal care product.

[0122] In a particular embodiment, the lecithin is present in the beverage in an amount of 5 to 100 ppm (parts per million) based on the total weight of the beverage or personal care product.

[0123] In a particular embodiment, the ester gum is present in the beverage or personal care product in an amount of 20 to 40 ppm (parts per million), based on the total weight of the beverage or personal care product.

[0124] In a particular embodiment, 1,2-propylene glycol is present in the beverage or personal care product in an amount of 5 to 50 ppm (parts per million), based on the total weight of the beverage or personal care product.

[0125] In a particular embodiment, water is present in the beverage or personal care product in an amount of 80 to 98 wt%, preferably 90 to 95 wt%, based on the total weight of the beverage or personal care product.

[0126] In a particular embodiment, sugar is present in the beverage or personal care product in an amount of 2 to 10 wt%, preferably 3 to 8 wt%, based on the total weight of the beverage or personal care product.

[0127] In a particular embodiment, citric acid is present in the beverage or personal care product in an amount of 0.05 to 5 wt %, preferably 0.1 to 0.5 wt %, based on the total weight of the beverage or personal care product.

[0128] In a particular embodiment, vitamin C is present in the beverage or personal care product in an amount of 0.005 to 1 wt %, preferably 0.01 to 0.05 wt %, based on the total weight of the beverage or personal care product.

[0129] In a particular embodiment, trisodium citrate dihydrate and / or sodium citrate is present in the beverage or personal care product in an amount of 0.005 to 0.5 wt %, preferably 0.01 to 0.02 wt %, based on the total weight of the beverage or personal care product.

[0130] In view of the above, the present invention provides a composition comprising a polar phase and a non-polar phase and a surfactant system, which allows a sufficiently high content of flavor oil in the composition.

[0131] Furthermore, compositions are provided which contain only acceptable natural surfactants but still exhibit good functionality.

[0132] In particular, the composition of the present invention can be conveniently used to prepare beverages or personal care products that have a clear appearance and exhibit sufficient stability during storage.

[0133] The specific objective technical problem of the present invention is therefore to provide a composition comprising a polar phase and a nonpolar phase, and a surfactant system comprising only naturally occurring surfactants.

[0134] Another particular objective technical problem of the present invention is to provide a composition comprising a polar phase and a nonpolar phase and a surfactant system which exhibits sufficient stability during storage.

[0135] Another particular objective technical problem of the present invention is to provide a composition comprising a polar phase and a nonpolar phase, and a surfactant system allowing sufficiently high amounts of flavour oils.

[0136] Another specific objective technical problem of the present invention is to provide a composition which can be used for preparing clear beverages or personal care products. DETAILED DESCRIPTION

[0137] Example

[0138] Embodiment 1:

[0139] 1. Preparation of Flavor Nanoemulsion

[0140] Flavor microemulsions according to Samples 1 to 3 were prepared as follows:

[0141] The polar phase was prepared by mixing steviol glycosides (steviol glycoside REBA 80) with water. The non-polar phase was prepared by mixing flavor oil (grapefruit oil) with lecithin (lipid lecithin H100) at a temperature of 20-25°C. After combining the non-polar phase with the polar phase, the mixture was homogenized by using a high-speed homogenizer (IKA, T25 Digital Ultra The mixture was pre-emulsified at 10.000 rpm for 5 minutes. Afterwards, the obtained pre-emulsion was homogenized using a 2-stage high-pressure homogenizer (SPXFLOW, APV-1000 laboratory homogenizer, USA) at 50 / 450 bar. The high-pressure treatment was repeated 3 times.

[0142] Table 1. Composition of flavor nanoemulsions.

[0143] sample 1 2 3 Element weight% weight% weight% Limonene 7 7 7 Ester glue 3 3 3 Lipid Lecithin H100 3 5 6 Stevioside SG95REBA80 3 5 4 water Add to 100 Add to 100 Add to 100

[0144] Further details of the ingredients used are given in Table 2 below:

[0145]

[0146] 2. Preparation of beverages using the flavor microemulsions according to samples 1 to 3

[0147] Beverages I to III were prepared by adding the flavor nanoemulsions of samples 1 to 3 (FNE 1 to 3) to the beverage base, respectively, according to Table 3 below. The pH of the beverages was 2.8.

[0148] Table 3. Composition of final beverages.

[0149]

[0150] *Z-average refers to the intensity-weighted mean hydrodynamic diameter

[0151] The droplet size of the beverages was measured by Zetasizer nano ZS (Malvern Instruments Limited, Worcs, UK). The turbidity of the beverages was measured by a portable turbidity meter (Hanna Instruments, HI93703, US) and reported in nephelometric turbidity units (NTU).

[0152] Beverages I to III were clear (translucent) in appearance due to low turbidity and droplet size. Based on appearance and turbidity, Beverages I to III exhibited good stability.

[0153] Embodiment 2:

[0154] 1. Preparation of flavor agent microemulsion

[0155] Flavor microemulsions according to Samples 1 to 6 were prepared by mixing together all ingredients shown in Table 4 on a stir plate at a temperature of 20 to 25°C.

[0156] Table 4. Composition of flavor microemulsions.

[0157] sample 1 2 3 4 5 6 Element weight% weight% weight% weight% weight% weight% Grapefruit Oil 35.00 32.50 30.00 27.50 25.00 38.54 Glucosylated steviol glycosides 28.00 26.00 24.00 22.00 - 25.17 Steviol glycoside REBA 80 - - - - 20.00 - Lipid Lecithin H100 7.00 6.50 6.00 5.50 5.00 6.29 1,2-Propanediol 10.00 11.67 13.33 15.00 25.00 10.00 water 20.00 23.33 26.67 30.00 25.00 20.00 total 100.00 100.00 100.00 100.00 100.00 100.00 Appearance Clear Clear Clear Clear Clear Clear

[0158] Further details of the ingredients used are given in Table 5 below:

[0159]

[0160] 2. Preparation of beverages using the flavor microemulsions according to samples 1 to 6

[0161] Beverages I to VI were prepared by adding the flavor microemulsions of samples 1 to 6 (FME 1-6) to the beverage base, respectively, according to Table 6 below. The pH of the beverages was 2.8.

[0162] Table 6. Composition of final beverages.

[0163]

[0164] *Z-average refers to the intensity-weighted mean hydrodynamic diameter

[0165] The droplet size of the beverages was measured by Zetasizer nano ZS (Malvern Instruments Limited, Worcs, UK). The turbidity of the beverages was measured by a portable turbidity meter (Hanna Instruments, HI93703, US) and reported in nephelometric turbidity units (NTU).

[0166] Beverages I to VI were clear (translucent) and stable in appearance due to low turbidity and droplet size.

Claims

1. A composition comprising: (1) Surfactant system, (2) a non-polar phase comprising flavor oils, and (3) Polar phase, The surfactant system comprises: - lecithin, and - diterpene glycoside and / or glucosylated diterpene glycoside, wherein the diterpene glycoside is steviol glycoside, wherein the composition comprises lecithin in an amount of 1 to 10% by weight, and the composition comprises diterpene glycoside and / or glucosylated diterpene glycoside in an amount of 1 to 40% by weight, and The mass ratio of diterpene glycoside and / or glucosylated diterpene glycoside to lecithin is 20:1 to 1:

10.

2. The composition according to claim 1, wherein the composition is an emulsion.

3. The composition according to claim 2, wherein the composition is a nanoemulsion or a microemulsion.

4. The composition according to claim 1, wherein the composition comprises lecithin in an amount of 2.5 to 7.5% by weight.

5. The composition according to claim 1, wherein the composition comprises the diterpene glycoside and / or the glucosylated diterpene glycoside in an amount of 2.5 to 30% by weight.

6. The composition according to claim 1, wherein the mass ratio of diterpene glycoside and / or glucosylated diterpene glycoside to lecithin is 10:1 to 1:

10.

7. The composition according to claim 1, wherein the diterpene glycoside is a steviol glycoside selected from the group consisting of stevioside ((4α)-13-[(2-O-β-D-pyranoglucopyranosyl-β-D-pyranoglucopyranosyl)oxy]-ent-kaurin-16-ene-18-acid β-D-pyranoglucopyranosyl ester), rebaudioside A ((4α)-13-[(2-O-β-D-pyranoglucopyranosyl-3-O-β-D-pyranoglucopyranosyl-β-D-pyranoglucopyranosyl)oxy]-ent-kaurin-16-ene-18-acid β-D-pyranoglucopyranosyl ester), )oxy]-kaurin-6-ene-8-acid β-D-glucopyranosyl ester), rebaudioside C ((4α)-13-[(O-6-deoxy-α-L-pyranosyl-(1→2)-O-[β-D-pyranosyl-(1→3)]-β-D-pyranosyl)oxy]kaurin-16-ene-18-acid β-D-pyranosyl glucopyranosyl ester), dulcoside A ((4α)-13-[[2-O-(6-deoxy-α-L-pyranosyl- pyranosyl]oxy]kaur-16-ene-18-oic acid β-D-glucopyranosyl ester), rebaudioside B ((4α)-13-[(O-β-D-pyranosyl-(1→2)-O-[β-D-pyranosyl-(1→3)])-β-D-pyranosyl)oxy]kaur-16-ene-18-oic acid), rebaudioside D ((4α)-13-[(O-β-D-pyranosyl-(1→2)-O-[β-D-pyranosyl-(1→3)])-β-D-pyranosyl)oxy]kaur-16-ene-18-oic acid), →3)]-β-D-pyranosyl-glucopyranosyl)oxy]-kaur-16-ene-18-acid 2-O-β-D-pyranosyl-β-D-pyranosyl glucopyranosyl ester), rebaudioside E (13-[(O-β-D-pyranosyl-(1,2)-O-[β-D-pyranosyl-glucopyranosyl)-oxy]-kaur-16-ene-18-acid (4')-O-β-D-pyranosyl-deoxy-(1,2)-O-β-D-pyranosyl glucopyranosyl ester), and mixtures thereof.

8. The composition of claim 1, wherein the glucosylated diterpene glycoside is a glucosylated steviol glycoside selected from the group consisting of glucosylated stevioside, glucosylated rebaudioside A, glucosylated rebaudioside C, glucosylated dulcoside A, glucosylated rebaudioside B, glucosylated rebaudioside D, glucosylated rebaudioside E, or any mixture thereof.

9. The composition of claim 1, wherein the composition comprises the flavor oil in an amount of 1 to 50 wt%.

10. The composition according to claim 9, wherein the composition comprises the flavor oil in an amount of 5 to 40% by weight.

11. The composition of claim 1, wherein the polar phase comprises water.

12. The composition according to claim 1, wherein the composition comprises water in an amount of 10 to 90 wt% based on the total weight of the composition.

13. The composition of claim 1, wherein the polar phase comprises a non-aqueous solvent selected from the group consisting of glycerol, 1,2-propylene glycol, benzyl alcohol, ethanol, propanol, isopropanol, 1,3-propylene glycol, butanol, butylene glycol, hexylene glycol, dipropylene glycol, ethoxydiglycol, triacetin, or any mixture thereof.

14. The composition of claim 13, wherein the polar non-aqueous solvent is glycerol or propylene glycol.

15. The composition according to claim 13, wherein the composition comprises the polar non-aqueous solvent in an amount of 5 to 40 wt%.

16. The composition according to claim 15, wherein the composition comprises the polar non-aqueous solvent in an amount of 10 to 25% by weight.

17. A method for preparing the composition of claim 1, The following steps are involved: - A non-polar phase comprising flavour oils is mixed with a polar phase in the presence of a surfactant system comprising lecithin and diterpene glycosides and / or glucosylated diterpene glycosides.

18. A method of preparing a flavored beverage or personal care product, The following steps are involved: - Adding the composition of claim 1 to beverages or personal care products.

19. A beverage or personal care product comprising the composition of claim 1.

20. Use of the composition according to claim 1 in preparing a flavored beverage or a personal care product.